Decouverte Pharma Private Limited
About Decouverte Pharma Private Limited
Data last updated:
Decouverte Pharma Private Limited is a private limited company based in Chennai, Tamil Nadu, India, recognised as a startup by DPIIT. It operates in the repair services segment of the electronics sector. It was incorporated on 22 April 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U52609TN2021PTC143030. Its GSTIN is 33AAICD4618G1ZU (Tamil Nadu).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Jembulingam Sarathi and Renuga.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Chennai, Tamil Nadu.
As per the financials filed for FY 2025, the company reported a revenue of ₹10.08 Lakh, a decline of 68% compared to the previous year. For the same year it recorded a net loss of ₹6.36 Lakh (net margin -63.1%) and EBITDA of -₹5.85 Lakh (EBITDA margin -58.1%).
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressPlot No.16 Door No.14/5 Ground Floor Dhanalakshmi Colony 2nd Street Saligram, Am, Chennai, Tamil Nadu, India – 600093
- IndustryElectrnoics, Repair Services
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Decouverte Pharma Private Limited
The main business activity of Decouverte Pharma is manufacturing. In detail, this covers manufacture of chemicals and chemical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | 20 | Manufacture of chemicals and chemical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Decouverte Pharma Private Limited FY 2025 filings available
Decouverte Pharma Private Limited reported revenue of ₹10.08 Lakh (down 68% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Decouverte Pharma Private Limited
Revenue fell 68% in the latest year. EBITDA fell 243% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Decouverte Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• |
| EBITDA | -₹5.85 Lakh | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹6.36 Lakh | •••• | •••• | •••• |
| Balance Sheet | ||||
| Share Capital | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• |
Financial Ratios of Decouverte Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | -58.1% | •••• | •••• | •••• |
| Net Profit Margin | -63.1% | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• |
| Liquidity and Debt | ||||
| Current Ratio | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• |
| Efficiency and Growth | ||||
| Asset Turnover | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Decouverte Pharma are in the company report.
Financial statements from FY 2022
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Decouverte Pharma Private Limited
Decouverte Pharma Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Manufacture of chemicals and chemical products). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Agri Doctor Bio Organic Private Limited | ₹10.57 Lakh (FY 2025) | •••• | •••• | -41.0% | •••• | Parbhani, Maharashtra, India |
| Forage Chemical Industries Private Limited | ₹10.52 Lakh (FY 2025) | •••• | •••• | 162.0% | •••• | Mumbai, Maharashtra, India |
| KNB Health Care Services Private Limited | ₹10.39 Lakh (FY 2024) | •••• | •••• | 6.0% | •••• | Delhi, India |
| KM Medicine Private Limited | ₹10.32 Lakh (FY 2025) | •••• | •••• | 2775.0% | •••• | Thane, Maharashtra, India |
| Prident Chemicals Private Limited | ₹10.09 Lakh (FY 2024) | •••• | •••• | •••• | Sanand, Gujarat, India | |
| Decouverte Pharma Private Limited this company | ₹10.08 Lakh (FY 2025) | •••• | •••• | -68.0% | •••• | Chennai, Tamil Nadu, India |
| Gallance Biotec Private Limited | ₹9.98 Lakh (FY 2025) | •••• | •••• | 66.0% | •••• | Delhi, India |
| Koks India Chemicals Private Limited | ₹9.98 Lakh (FY 2024) | •••• | •••• | 124.0% | •••• | Ahmednagar, Maharashtra, India |
| Priscilla Lifesciences Private Limited | ₹9.9 Lakh (FY 2024) | •••• | •••• | •••• | New Delhi, Delhi, India | |
| Veerochan Petro Chem Private Limited | ₹9.86 Lakh (FY 2025) | •••• | •••• | 722.0% | •••• | Begusarai, Bihar, India |
| Epitomneutraceutical Private Limited | ₹9.81 Lakh (FY 2024) | •••• | •••• | 1907.0% | •••• | Mumbai, Maharashtra, India |
Peers are the five companies nearest above and the five nearest below Decouverte Pharma by revenue in the same principal business activity (Manufacture of chemicals and chemical products), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Board of Directors of Decouverte Pharma Private Limited
Decouverte Pharma has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Jembulingam Sarathi | Director | 22 Apr 2021 | 5 Years 5 Months | Current |
| Renuga | Director | 22 Sep 2023 | 3 Years 0 Months | Current |
Ownership and Shareholding of Decouverte Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Decouverte Pharma Private Limited
Decouverte Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Decouverte Pharma Private Limited
Decouverte Pharma Private Limited has a workforce of 0 employees as of Apr 11, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Decouverte Pharma Private Limited
Decouverte Pharma Private Limited has 4 board changes on record since 2021: 2 appointments and 2 cessations. The latest: Renuga ceased to be Additional Director on 29 Sep 2023.
Credit Ratings, Litigation & Regulatory Alerts for Decouverte Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Decouverte Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Decouverte Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Decouverte Pharma Private Limited
Decouverte Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 33AAICD4618G1ZU | Tamil Nadu | Active | 10 Jun 2022 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Decouverte Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Decouverte Pharma Private Limited
Decouverte Pharma is an active private limited company based in Chennai, Tamil Nadu, India. The company works in repair services, within the electronics industry. It was incorporated on 22 April 2021 (5+ years old) and is registered under CIN U52609TN2021PTC143030.
Decouverte Pharma reported revenue of ₹10.08 Lakh for FY 2025 (down 68% YoY).
Decouverte Pharma has 2 current directors:
- Jembulingam Sarathi - Director
- Renuga - Director
Decouverte Pharma reported a net loss of ₹6.36 Lakh (net margin -63.1%) and EBITDA of -₹5.85 Lakh (EBITDA margin -58.1%) for FY 2025, as per its filed financial statements.
The GSTIN of Decouverte Pharma is 33AAICD4618G1ZU, registered in Tamil Nadu.
The CIN (Corporate Identification Number) of Decouverte Pharma is U52609TN2021PTC143030. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Decouverte Pharma was incorporated on 22 April 2021, making it 5+ years old. It is registered with the Registrar of Companies, Chennai.
The peers of Decouverte Pharma by revenue are Agri Doctor Bio Organic Private Limited, Forage Chemical Industries Private Limited, KNB Health Care Services Private Limited, KM Medicine Private Limited, Prident Chemicals Private Limited and 5 more, all in the same principal business activity (Manufacture of chemicals and chemical products).
Renuga ceased to be Additional Director on 29 Sep 2023. Renuga was appointed as Director on 22 Sep 2023. Balaji Vadivel ceased to be Director on 26 Aug 2023. Decouverte Pharma has 4 board changes on record in total.
Yes, Decouverte Pharma is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
The registered office of Decouverte Pharma is at Plot No.16 Door No.145 Ground Floor Dhanalakshmi Colony 2nd Street Saligram, Am, Chennai, Tamil Nadu, India – 600093.